Strong Balance Sheet / Low LeverageA robust equity base and low debt-to-equity reduce financial risk and preserve flexibility. Over the next 2-6 months this balance sheet strength supports funding for working capital, selective capex or strategic action without forcing dilutive financing, aiding durability.

Sustainable Gross MarginsStrong gross margins imply pricing power or operational efficiency in manufacturing formulations. This margin cushion helps absorb revenue volatility, supports reinvestment in production or product quality, and underpins longer-term profitability if cost discipline continues.

Diversified Sales Channels & Product MixSelling branded/generic formulations across domestic, institutional and export markets plus a therapeutic portfolio including anti-infectives provides diversified demand sources. That manufacturing and channel breadth lowers single-market risk and supports steadier volumes over months.

Bears Say

Declining Revenue TrendA meaningful revenue contraction reduces scale, erodes bargaining power with suppliers and distributors, and limits ability to cover fixed manufacturing costs. If the top-line trend persists beyond a few quarters it can pressure margins, cash flow and long-term growth prospects.

Negative Operating & Free Cash FlowOperating cash flow turning negative signals core operations aren't generating sufficient cash to sustain the business. Even with low leverage, persistent cash deficits can force external financing, curtail reinvestment or dividends, and raise liquidity risk over the medium term.

Earnings DeteriorationSharp EPS decline and weaker net margins show profitability stress beyond gross-margin dynamics, implying higher SG&A, other costs or one-offs. Continued earnings deterioration undermines retained earnings, reduces financial buffer and constrains strategic initiatives over coming quarters.

Albert David Ltd News

Albert David to Close Trading Window Ahead of Q3 FY2025-26 Results

An update from Albert David Ltd ( ($IN:ALBERTDAVD) ) is now available. Albert David Limited has announced that...

2M ago

Albert David Limited Submits SEBI Compliance Certificate

Albert David Ltd ( ($IN:ALBERTDAVD) ) just unveiled an announcement. Albert David Limited has submitted a compliance certificate...

5M ago

ALBERTDAVD FAQ

What was Albert David Ltd’s price range in the past 12 months?

Albert David Ltd lowest stock price was ₹670.00 and its highest was ₹959.35 in the past 12 months.

What is Albert David Ltd’s market cap?

Albert David Ltd’s market cap is ₹4.30B.

When is Albert David Ltd’s upcoming earnings report date?

Albert David Ltd’s upcoming earnings report date is May 20, 2026 which is in 87 days.

How were Albert David Ltd’s earnings last quarter?

Albert David Ltd released its earnings results on Feb 11, 2026. The company reported ₹26.815 earnings per share for the quarter, beating the consensus estimate of N/A by ₹26.815.

Is Albert David Ltd overvalued?

According to Wall Street analysts Albert David Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Albert David Ltd pay dividends?

Albert David Ltd pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.66%. See more information on Albert David Ltd dividends here

What is Albert David Ltd’s EPS estimate?

Albert David Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Albert David Ltd have?

Albert David Ltd has 5,707,162 shares outstanding.

What happened to Albert David Ltd’s price movement after its last earnings report?

Albert David Ltd reported an EPS of ₹26.815 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.204%.

Which hedge fund is a major shareholder of Albert David Ltd?

Currently, no hedge funds are holding shares in IN:ALBERTDAVD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Albert David Ltd

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries. The company was incorporated in 1938 and is headquartered in Kolkata, India.